<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04295265</url>
  </required_header>
  <id_info>
    <org_study_id>UW 19-552</org_study_id>
    <nct_id>NCT04295265</nct_id>
  </id_info>
  <brief_title>Smartphone Message to Improve the Drug Compliance in Pregnant Women.</brief_title>
  <official_title>A Randomized Controlled Trial on the Use of Smartphone Message to Improve the Drug Compliance in Pregnant Women.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      As technology advances, smartphones are now widely available and can provide a convenient and&#xD;
      effective means to improve drug compliance by sending an electronic reminder on a regular&#xD;
      basis. In a meta-analysis of 16 RCTs in assessing of drug compliance in chronic diseases,&#xD;
      text message significantly improves medication compliance (OR, 2.11; 95% CI, 1.52-2.93; P &lt;&#xD;
      0.001). The drug compliance improves from 50% to 67.8%, or an absolute increase of 17.8%.&#xD;
      Further evaluation is required as most of these RCTs relies on self-reported compliance. This&#xD;
      data may be not applicable to pregnant women and trial of using this approach to improve drug&#xD;
      compliance during pregnancy is lacking.&#xD;
&#xD;
      The investigators hypothesize that the use of smartphone message will improve the drug&#xD;
      compliance in pregnant women requiring long term medications. The investigators propose a&#xD;
      randomized controlled trial to evaluate the effect of smartphone message.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2020</start_date>
  <completion_date type="Anticipated">February 28, 2024</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compliance</measure>
    <time_frame>through study completion, an average of 9months</time_frame>
    <description>number of tablet taken/ total number of tablets expected to take</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">228</enrollment>
  <condition>Pregnancy Related</condition>
  <arm_group>
    <arm_group_label>Smartphone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receive daily whatsapp/ SMS message remind the drug intake.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>receive instruction to take the medication at recruitment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>smartphone message</intervention_name>
    <description>Receive daily whatsapp/ SMS message to remind the drug intake</description>
    <arm_group_label>Smartphone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All women age â‰¥ 18 years old&#xD;
&#xD;
          -  Able to receive electronic reminder through smartphohne&#xD;
&#xD;
          -  Gestational age less than 16 completed weeks as defined by pelvic ultrasound&#xD;
&#xD;
          -  Part 1: Need to take aspirin or progesterone for prevention of pre-eclampsia or&#xD;
             preterm birth respectively&#xD;
&#xD;
          -  Part 2: Given multivitamin as health supplementation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        For Part 1:&#xD;
&#xD;
          -  History of adverse reaction to aspirin&#xD;
&#xD;
          -  History of adverse reaction to progesterone&#xD;
&#xD;
          -  History of breast or genital tract malignancy&#xD;
&#xD;
          -  History of suspected thromboembolic disease&#xD;
&#xD;
          -  Congenital uterine anomaly&#xD;
&#xD;
          -  Unwillingness or inability to comply with study procedures&#xD;
&#xD;
          -  Known paternal or maternal abnormal karyotype&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 23, 2020</study_first_submitted>
  <study_first_submitted_qc>March 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2020</study_first_posted>
  <last_update_submitted>March 2, 2020</last_update_submitted>
  <last_update_submitted_qc>March 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

